A comparison of ranitidine bismuth citrate-clarithromycin (RBC-C) dual therapy vs. omeprazole, clarithromycin, amoxycillin (OCA) triple therapy given for 7 days in the treatment of H-pylori infection

被引：0

作者：

van Zanten, SJOV

Chiba, N

Barkun, AN

Fallone, CA

Farley, A

Cockeram, A

Dallaire, C

Simms, L

Nicholls, B

机构：

[1] Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada

[2] McMaster Univ, Hamilton, ON, Canada

[3] McGill Univ, Ctr Hlth, Montreal, PQ, Canada

[4] Ctr Gastroenterol Montreal, Montreal, PQ, Canada

[5] St John Reg Hosp, St John, NB, Canada

[6] Hosp St Francois Assise, Quebec City, PQ, Canada

[7] Glaxo Wellcome Canada Inc, Mississauga, ON, Canada

来源：

GASTROENTEROLOGY | 2001年 / 120卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2978

引用

页码：A586 / A586

页数：1

共 50 条

[1] Ranitidine bismuth citrate (RBC) or omeprazole (O) with clarithromycin (C) and amoxycillin (A) for one week in the eradication of H-pylori
Cabooter, M
Dekkers, CPM
Theodors, A
Vanweerts, S
[J]. GASTROENTEROLOGY, 1999, 116 (04) : A345 - A345
[2] Dual therapy with ranitidine bismuth citrate and clarithromycin is superior to omeprazole and amoxycillin in the cure of Helicobacter pylori infection
Kolkman, JJ
Tan, TG
OudkerkPool, M
vanKleef, WA
Geraedts, AAM
Meuwissen, SGM
[J]. GASTROENTEROLOGY, 1997, 112 (04) : A180 - A180
[3] Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with H-pylori infection
Cestari, R
Corti, G
Formenti, A
Galli, F
Gatti, M
Marotta, F
Milesi, F
Paterlini, A
Piubello, W
Ravelli, P
Tonini, G
Ubiali, P
Valenghi, D
Fina, P
Olivieri, A
Tosatto, R
[J]. GUT, 1998, 43 : A83 - A84
[4] Efficacy of six days triple therapy with pantoprazole plus clarithromycin and amoxycillin versus omeprazole plus clarithromycin and amoxycillin for H-pylori eradication.
Domínguez-Martín, A
Domínguez-Muñoz, A
Muñoz, S
Alonso, JB
González, MD
[J]. GASTROENTEROLOGY, 1998, 114 (04) : A107 - A107
[5] Dual or triple therapy combining omeprazole with amoxicillin and/or clarithromycin for H-pylori infection.
Burette, A
Lamy, V
Ligny, G
Cabooter, M
Ramdani, B
Ectors, N
Glupczynski, Y
[J]. GASTROENTEROLOGY, 1997, 112 (04) : A80 - A80
[6] Ranitidine bismuth citrate with clarithromycin given for 7 days effectively eradicates H-pylori.
Thomson, ABR
Hasselgren, G
Keelan, M
Lee, J
Matisko, A
Sinclair, P
Röhss, K
[J]. GASTROENTEROLOGY, 1998, 114 (04) : A310 - A310
[7] Ten day triple therapy with Ranitidine bismuth citrate (RBC), amoxicillin and clarithromycin in the eradication of H-pylori.
Vakil, N
Cutler, AF
[J]. GASTROENTEROLOGY, 1998, 114 (04) : A317 - A317
[8] Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection
Cestari, R
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (10) : 991 - 996
[9] Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection
Graham, DY
Hoffman, J
Anderson, SY
Qureshi, W
Osato, MS
El-Zimaity, HMT
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (02) : 169 - 172
[10] Metronidazole resistance does not influence the efficacy of triple therapy with ranitidine bismuth citrate (RBC), clarithromycin (CLA) and metronidazole (MET) for H-pylori (Hp) infection.
van der Wouden, EJ
Thijs, JC
van Zwet, AA
Kooy, A
Kleibeuker, JH
[J]. GASTROENTEROLOGY, 1998, 114 (04) : A323 - A323

← 1 2 3 4 5 →